Literature DB >> 9495011

Substitution of Arg-244 by Cys or Ser in SHV-1 and SHV-5 beta-lactamases confers resistance to mechanism-based inhibitors and reduces catalytic efficiency of the enzymes.

P Giakkoupi1, E Tzelepi, N J Legakis, L S Tzouvelekis.   

Abstract

The conserved residue Arg-244 was substituted by the smaller uncharged amino acids Cys and Ser in SHV-1 and SHV-5 beta-lactamases by a PCR-based site-specific mutagenesis procedure. The mutant beta-lactamases displayed decreased susceptibility to clavulanate and, to a lesser extent, to tazobactam and sulbactam. As shown in comparative MIC determinations, R244C and R244S enzymes retained a residual penicillinase activity while their activity towards cephalosporins was drastically diminished. The respective SHV-5 mutants were unable to hydrolyze oxyimino-beta-lactams except aztreonam. The impaired catalytic activity of the mutant beta-lactamases was mainly due to the lowering of affinity for beta-lactam substrates. The above alterations were more pronounced in the R244C mutants. These results provide information on the mode of involvement of Arg-244 in (a) inactivation by beta-lactamase inhibitors and (b) the proper positioning of beta-lactams in the active site of SHV enzymes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9495011     DOI: 10.1111/j.1574-6968.1998.tb12889.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  5 in total

1.  Kinetic analysis of an inhibitor-resistant variant of the OHIO-1 beta-lactamase, an SHV-family class A enzyme.

Authors:  S Lin; M Thomas; D M Shlaes; S D Rudin; J R Knox; V Anderson; R A Bonomo
Journal:  Biochem J       Date:  1998-07-15       Impact factor: 3.857

2.  Combinatorial active-site variants confer sustained clavulanate resistance in BlaC β-lactamase from Mycobacterium tuberculosis.

Authors:  Philippe Egesborg; Hélène Carlettini; Jordan P Volpato; Nicolas Doucet
Journal:  Protein Sci       Date:  2014-12-30       Impact factor: 6.725

Review 3.  Three decades of beta-lactamase inhibitors.

Authors:  Sarah M Drawz; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

4.  Crystal structure of the extended-spectrum β-lactamase PER-2 and insights into the role of specific residues in the interaction with β-lactams and β-lactamase inhibitors.

Authors:  Melina Ruggiero; Frédéric Kerff; Raphaël Herman; Frédéric Sapunaric; Moreno Galleni; Gabriel Gutkind; Paulette Charlier; Eric Sauvage; Pablo Power
Journal:  Antimicrob Agents Chemother       Date:  2014-07-28       Impact factor: 5.191

5.  Assessing the Potency of β-Lactamase Inhibitors with Diverse Inactivation Mechanisms against the PenA1 Carbapenemase from Burkholderia multivorans.

Authors:  Michiyoshi Nukaga; Michael J Yoon; Magdalena A Taracilia; Tyuji Hoshino; Scott A Becka; Elise T Zeiser; Joseph R Johnson; Krisztina M Papp-Wallace
Journal:  ACS Infect Dis       Date:  2021-03-16       Impact factor: 5.084

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.